Biozentrum, University of Basel
Biozentrum is a University of Basel life sciences research institute founded in 1971 that runs ~32 research groups across molecular and biomedical science, operates 11 shared technology platforms, delivers degree programs from BSc to PhD, and transfers IP via spin-outs such as SEAL Therapeutics AG.
- Company typePrivate
- Founded1971
- HeadquartersBasel, Switzerland
- Headcount501–1,000
- GTM typeB2B
- OfferingServices
What Biozentrum, University of Basel does
Biozentrum is one of the world's leading academic research institutes for molecular and biomedical basic research, founded in 1971 and embedded within the University of Basel in Basel, Switzerland. It is organized around approximately 32 research groups spanning structural biology (NMR spectroscopy by Sebastian Hiller; electron diffraction and cryo-EM by Jan Pieter Abrahams and Ben Engel), microbiology, infection biology, developmental biology, neuroscience, and computational biology (Richard Neher, Erik van Nimwegen, Mihaela Zavolan), operating 11 shared technology platforms including BioEM Lab, Biophysics Facility, FACS Core Facility, Imaging Core Facility, Proteomics Core Facility, Research Instrumentation Facility, sciCORE high-performance computing, the Swiss High-field NMR Facility, a Bioinformatics Core Facility, and the Genomics Facility Basel run jointly with ETH Zurich D-BSSE.
The institute trains scientists at every level: BSc in Biology, BSc in Computational Sciences, MSc in Molecular Biology, MSc in Physics of Life, a Diploma in Biotechnology, an International PhD Program with named PhD Fellowships, and postdoctoral positions, supported by centralized services (communications, electronics and mechanical workshops, media/lab ware preparation, safety, and stores). Industry translation happens through a structured technology transfer program and spin-outs such as SEAL Therapeutics AG, with structural-biology IP historically licensed through the institute's venture arm.
Funding flows from the University of Basel budget, the Swiss National Science Foundation (including Ambizione Fellowships), the European Research Council (ERC Starting Grants), and philanthropic donations; the institute has no commercial pricing model. Customer segments are primarily BSc, MSc, and PhD students; postdoctoral researchers; and, secondarily, industry partners who collaborate, license technologies, and access the talent pipeline. Strategic partnerships include Paul Scherrer Institute (dual appointments and structural biology collaboration), ETH Zurich D-BSSE (shared Genomics Facility Basel), and historical and ongoing relationships with MRC LMB Cambridge, Leiden University, EPFL, the University of Oxford, and Harvard Medical School.
Biozentrum, University of Basel firmographics
Firmographics- Name
- Biozentrum, University of Basel
- Legal name
- Biozentrum, University of Basel
- Website
- https://biozentrum.unibas.ch
- Company type
- Private
- Founded year
- 1971
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Short description
- Biozentrum is a University of Basel life sciences research institute founded in 1971 that runs ~32 research groups across molecular and biomedical science, operates 11 shared technology platforms, delivers degree programs from BSc to PhD, and transfers IP via spin-outs such as SEAL Therapeutics AG.
- Ownership category
- akta.pro rank
Biozentrum, University of Basel industry classification
Industry- Product category
- Academic Research Institute
- NAICS
- Research and Development in the Physical, Engineering, and Life Sciences (54171)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Translational Medicine & Biomarkers (HLAIALAF)
- akta.pro secondary industries
- Proteomics & Mass Spectrometry Services (HLAGANAB), Material Characterization & Spectroscopy (NMR/FTIR/MS) (HLAGADAK)
Keywords
Where Biozentrum, University of Basel is headquartered
LocationHeadquarters
- HQ city
- Basel
- HQ country
- Switzerland
- HQ region
- Europe
Offices1 record
Markets served
Biozentrum, University of Basel business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Infrastructure, Operations
Revenue model
- Government and University Funding: Core funding from the University of Basel and Swiss government sources for basic research activities.
- Research Grants: Competitive research grants from Swiss National Science Foundation (SNSF), European Research Council (ERC), and other funding bodies supporting specific research projects.
- Technology Ventures: Technology transfer through spin-off companies like SEAL Therapeutics AG commercializing research innovations.
- Education Programs: Revenue from degree programs including BSc, MSc, and PhD programs for domestic and international students.
- Donations: Voluntary contributions from alumni, private donors, and philanthropic organizations supporting research excellence.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels7 records
Biozentrum, University of Basel product offering
Product offeringCore offering
Biozentrum is a university research institute conducting molecular and biomedical basic research through approximately 32 research groups. It operates state-of-the-art technology platforms (NMR, cryo-EM, proteomics, bioinformatics) and offers educational degree programs from BSc to PhD level. The institute also transfers research discoveries through technology ventures such as SEAL Therapeutics AG.
Product overview
Biozentrum, University of Basel is a world-leading institute for molecular and biomedical basic research. The institute offers a comprehensive portfolio of educational programs at Bachelor, Master, and PhD levels, alongside state-of-the-art technology platforms that support cutting-edge scientific research. The educational offerings include BSc programs in Biology and Computational Sciences, MSc programs in Molecular Biology and Physics of Life, a Diploma in Biotechnology, an International PhD Program with fellowships, and Summer Schools. Research infrastructure consists of numerous technology platforms including BioEM Lab, Biophysics Facility, FACS Core Facility, Imaging Core Facility, Proteomics Core Facility, Research Instrumentation Facility, Research IT, sciCORE, Swiss High-field NMR Facility, Bioinformatics Core Facility, and Genomics Facility Basel. The institute also supports technology ventures such as SEAL Therapeutics AG. These components work together to advance molecular and biomedical research while training the next generation of scientists.
Differentiator
Problem solved
Functional benefit
Products and services
- BSc in Biology Bachelor of Science program in Biology offering early integration into active research with intensive mentoring for undergraduate students.
- BSc in Computational Sciences Bachelor of Science program in Computational Sciences combining computational methods with biological research applications.
- MSc in Molecular Biology Master of Science program in Molecular Biology with emphasis on early integration into active research environments.
- MSc in Physics of Life Master of Science program in Physics of Life combining physics and biology approaches to study living systems.
- Diploma in Biotechnology Diploma program in Biotechnology providing applied training in biotechnology methods and applications.
- International PhD Program Comprehensive PhD program offering exceptional research expertise, state-of-the-art technology facilities, and interdisciplinary teaching for doctoral researchers worldwide.
- Biozentrum PhD Fellowships Fellowship opportunities providing financial support for PhD students conducting research at the Biozentrum.
- Summer Schools Summer programs including Biozentrum Research Summer and Basel Summer Science Academy for students seeking intensive research exposure.
- Technology Platforms State-of-the-art research infrastructure including BioEM Lab, Biophysics Facility, FACS Core Facility, Imaging Core Facility, Proteomics Core Facility, Research Instrumentation Facility, Research IT, sciCORE, Swiss High-field NMR Facility, Bioinformatics Core Facility, and Genomics Facility Basel.
- Research Services Central research support services including Communications, Central Electronics Workshop, Central Mechanical Workshop, Events & Courses, Media & Lab Ware Preparation, Safety, and Store & Supply.
- SEAL Therapeutics AG Technology venture spin-off from the Biozentrum focused on translating research discoveries into therapeutic applications.
Quantifiable outcome
- Nobel Prize, Lasker Award, Gairdner Award, and Louis Jeantet Prize for Medicine winners have emerged from the institute
Companies that use Biozentrum, University of Basel
Customer profileSegments5 records
Ideal customer profiles5 records
Biozentrum, University of Basel technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration9 records
Feature7 records
Biozentrum, University of Basel partnerships and signals
Strategic signalPartnerships
Nine partnerships are on record, tiered core, major and minor.
- Paul Scherrer Institute (PSI)coreProf. Jan Pieter Abrahams holds positions at both the Biozentrum and PSI, focusing on structural analysis using electron diffraction and advanced imaging techniques. Research collaboration between the two institutions enables shared access to cutting-edge instrumentation.
- SEAL Therapeutics AGcoreTechnology venture spin-off from Biozentrum focused on translating research discoveries into therapeutic applications. Part of the Biozentrum's technology transfer strategy.
- MRC Laboratory of Molecular Biology, CambridgemajorProf. Jan Pieter Abrahams spent seven years as a staff scientist at MRC LMB Cambridge. Historical partnership involving significant researcher exchange and collaboration.
- Leiden UniversitymajorProf. Jan Pieter Abrahams was Professor of Structural Biology at Leiden University for 17 years before joining Biozentrum. Ongoing collaboration includes guest speakers like Prof. Gilles van Wezel.
- EPFLminorBiozentrum alumnus Prof. Henning Stahlberg from EPFL participated in the farewell symposium for Prof. Abrahams, indicating continued academic collaboration.
- University of OxfordmajorProf. Anissa Kempf conducted postdoctoral research with Gero Miesenböck at the Centre for Neural Circuits and Behaviour at Oxford before joining Biozentrum. Ongoing collaborative relationship in sleep research.
- Harvard Medical SchoolminorProf. Sebastian Hiller conducted postdoctoral research at Harvard Medical School, maintaining international research connections.
- Bioinformatics Core FacilitycoreShared bioinformatics facility between Biozentrum and other Swiss biomedical research institutions, providing computational biology support.
- Genomics Facility BaselcoreShared genomics facility operated jointly with ETH Zurich's Department of Biosystems Science and Engineering (D-BSSE), providing sequencing and genomics services.
Scale indicators6 records
Recent moves6 records
Expansion highlights5 records
Biozentrum, University of Basel competitors and assessment
Company assessmentBroad incumbents
- Karolinska Institutet: Sweden's leading medical university with substantial molecular and biomedical research activity and a similar blend of educational programs, technology platforms, and translational research.
- Institut Pasteur: Large French non-profit research institute with broader scope (microbiology, immunology, neuroscience) but operating in the same academic basic-research model with technology platforms and spin-off activity.
- Broad Institute of MIT and Harvard: Large joint MIT/Harvard genomics and chemical biology institute combining core technology platforms (similar to Biozentrum's platform model) with greater scale and industry-partnership throughput.
- Wellcome Sanger Institute: UK-based genomic and cellular biology institute with shared core facility / technology platform operations model and a comparable funding mix of foundational grant and project funding.
- The Rockefeller University: US private graduate university dedicated exclusively to biomedical research with a small-lab, technology-empowered model highly analogous to Biozentrum's research-group structure.
Direct peers
- ETH Zurich Department of Biology: Swiss federal university life-sciences department with overlapping molecular biology and structural biology programs; shares the Genomics Facility Basel with Biozentrum and competes for the same Swiss talent pool.
- Max Planck Institute for Molecular Cell Biology and Genetics: Max Planck's Dresden-based institute focused on molecular cell biology and genetics with a similar structure of independent research groups and core technology platforms.
- MRC Laboratory of Molecular Biology: UK MRC-funded research institute covering structural biology, cell biology, and neurobiology — historically a partner of Biozentrum via shared researchers and a directly comparable world-leading molecular biology institute.
- Friedrich Miescher Institute for Biomedical Research: Basel-based, non-profit biomedical research institute affiliated with the University of Basel and Novartis Research Foundation, operating in molecular biology and biomedical basic research with a comparable headcount and funding model.
- EPFL School of Life Sciences: Swiss federal technology school life-sciences school with comparable molecular biology, bioengineering, and neuroscience programs and similar technology-platform model.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Biozentrum, University of Basel social profiles
Digital presenceBiozentrum, University of Basel financial estimates
Financial estimateRevenue estimate
Valuation estimate
Biozentrum, University of Basel leadership team
Management profileNumber of profiles
Profiles4 records
Biozentrum, University of Basel subsidiaries and ownership
Company hierarchySubsidiaries1 record
Biozentrum, University of Basel funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Biozentrum, University of Basel M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Biozentrum, University of Basel
What does Biozentrum, University of Basel do?
Biozentrum is a university research institute conducting molecular and biomedical basic research through approximately 32 research groups. It operates state-of-the-art technology platforms (NMR, cryo-EM, proteomics, bioinformatics) and offers educational degree programs from BSc to PhD level. The institute also transfers research discoveries through technology ventures such as SEAL Therapeutics AG.
Is Biozentrum, University of Basel a public or private company?
Biozentrum, University of Basel is a private company. It is classified as state government owned and is currently operating.
When was Biozentrum, University of Basel founded?
Biozentrum, University of Basel was founded in 1971. It employs 501 to 1,000 people.
Where is Biozentrum, University of Basel based?
Biozentrum, University of Basel is headquartered in Basel, Switzerland, in the Europe region.
How does Biozentrum, University of Basel make money?
Five revenue lines are on record. Government and University Funding is the primary driver. The others are research Grants, technology Ventures, education Programs and donations.
Who are Biozentrum, University of Basel's main competitors?
Broad incumbents on record are Karolinska Institutet, Institut Pasteur, Broad Institute of MIT and Harvard, Wellcome Sanger Institute and The Rockefeller University. Direct peers are ETH Zurich Department of Biology, Max Planck Institute for Molecular Cell Biology and Genetics, MRC Laboratory of Molecular Biology, Friedrich Miescher Institute for Biomedical Research and EPFL School of Life Sciences.
Does Biozentrum, University of Basel have an API?
No public API is recorded for Biozentrum, University of Basel.
What industry is Biozentrum, University of Basel in?
Biozentrum, University of Basel's product category is Academic Research Institute. Its primary akta.pro industry code is HLAIALAF, Translational Medicine & Biomarkers, with a secondary code of HLAGANAB, Proteomics & Mass Spectrometry Services. Its NAICS code is 54171 and its SIC code is 8731.